The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years

BACKGROUND: In its first 8 years, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) achieved an unprecedentedly rapid scale-up: >1.9 billion treatments with anti-filarial drugs (albendazole, ivermectin, and diethylcarbamazine) were provided via yearly mass drug administration (MDA) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottesen, Eric A., Hooper, Pamela J., Bradley, Mark, Biswas, Gautam
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556399/
https://www.ncbi.nlm.nih.gov/pubmed/18841205
http://dx.doi.org/10.1371/journal.pntd.0000317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556399/
https://www.ncbi.nlm.nih.gov/pubmed/18841205
http://dx.doi.org/10.1371/journal.pntd.0000317

Ejemplares similares